BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26919054)

  • 1. The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan.
    Tsai CJ; Cheng C; Chou PH; Lin CH; McInnis MG; Chang CL; Lan TH
    J Affect Disord; 2016 May; 196():71-7. PubMed ID: 26919054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.
    Yerevanian BI; Koek RJ; Mintz J
    J Affect Disord; 2007 Nov; 103(1-3):5-11. PubMed ID: 17628692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018.
    Chan JKN; Wong CSM; Fang CZ; Hung SC; Lo HKY; Chang WC
    Epidemiol Psychiatr Sci; 2024 May; 33():e31. PubMed ID: 38779809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder.
    Song J; Sjölander A; Joas E; Bergen SE; Runeson B; Larsson H; Landén M; Lichtenstein P
    Am J Psychiatry; 2017 Aug; 174(8):795-802. PubMed ID: 28595491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suicide risk in bipolar disorder during treatment with lithium and divalproex.
    Goodwin FK; Fireman B; Simon GE; Hunkeler EM; Lee J; Revicki D
    JAMA; 2003 Sep; 290(11):1467-73. PubMed ID: 13129986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.
    Collins JC; McFarland BH
    J Affect Disord; 2008 Apr; 107(1-3):23-8. PubMed ID: 17707087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
    Hayes JF; Pitman A; Marston L; Walters K; Geddes JR; King M; Osborn DP
    JAMA Psychiatry; 2016 Jun; 73(6):630-7. PubMed ID: 27167638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium, anticonvulsants and suicidal behavior in bipolar disorder.
    Yerevanian BI; Koek RJ; Mintz J
    J Affect Disord; 2003 Feb; 73(3):223-8. PubMed ID: 12547290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood stabilizers and risk of all-cause, natural, and suicide mortality in bipolar disorder: A nationwide cohort study.
    Chen PH; Tsai SY; Chen PY; Pan CH; Su SS; Chen CC; Kuo CJ
    Acta Psychiatr Scand; 2023 Mar; 147(3):234-247. PubMed ID: 36367926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
    Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
    J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium and suicide prevention in bipolar disorder.
    Benard V; Vaiva G; Masson M; Geoffroy PA
    Encephale; 2016 Jun; 42(3):234-41. PubMed ID: 27000268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar disorders.
    McIntyre RS; Berk M; Brietzke E; Goldstein BI; López-Jaramillo C; Kessing LV; Malhi GS; Nierenberg AA; Rosenblat JD; Majeed A; Vieta E; Vinberg M; Young AH; Mansur RB
    Lancet; 2020 Dec; 396(10265):1841-1856. PubMed ID: 33278937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between use of mood stabilizers and risk of cataract: A population-based nested case-control study.
    Chu CS; Lin CH; Lan TH; Chou PH
    J Affect Disord; 2018 Feb; 227():79-81. PubMed ID: 29053979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to mood stabilizers.
    Calabrese JR; Fatemi SH; Kujawa M; Woyshville MJ
    J Clin Psychopharmacol; 1996 Apr; 16(2 Suppl 1):24S-31S. PubMed ID: 8707997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicidal ideation and pharmacotherapy among STEP-BD patients.
    Goldberg JF; Allen MH; Miklowitz DA; Bowden CL; Endick CJ; Chessick CA; Wisniewski SR; Miyahara S; Sagduyu K; Thase ME; Calabrese JR; Sachs GS
    Psychiatr Serv; 2005 Dec; 56(12):1534-40. PubMed ID: 16339615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse.
    Bowden CL
    Curr Psychiatry Rep; 2000 Dec; 2(6):490-4. PubMed ID: 11123000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics.
    Yerevanian BI; Koek RJ; Mintz J
    J Affect Disord; 2007 Nov; 103(1-3):23-8. PubMed ID: 17604119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006-2019.
    Lin CH; Chan HY; Chen CC; Chou FH
    J Affect Disord; 2022 Dec; 318():386-392. PubMed ID: 36103936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.